Back to 
HBK INVESTMENTS L P
HBK INVESTMENTS L P
ITCI2 quarters
Position history for HBK INVESTMENTS L P's holdings in INTRA-CELLULAR THERAPIES INC
As of its Q1 2025 13F, HBK Investments held 4,385,000 shares of ITCI (Intra-Cellular Therapies), worth $578.5M. ITCI was 8.2% of HBK Investments' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$578.5M
Total Shares Change
-4.4M
Quarter-by-Quarter History
Other major holders of ITCI: VANGUARD GROUP INC, BlackRock, Inc., FMR LLC